Assessing Barriers and Plan of Cervical Cancer Prevention Strategies from Multiple Perspectives in China
Mengdi Ji · Deep Blue (University of Michigan) · 2025
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Deep Blue (University of Michigan) · University of Michigan · dissertation · 2025
Abstract
Cervical cancer is the fourth most common cancer among women globally, with China accounting for 18% of cases and 17% of deaths. Human papillomavirus (HPV) vaccination, screening, and timely follow-up can substantially reduce this burden. The World Health Organization (WHO) recommends a two-dose HPV schedule for girls aged 9–14 and a three-dose schedule for those aged ≥15. In China, however, coverage among the WHO target group remains low despite pilot programs. Reliance on three-dose schedules for older adolescents contributes to incomplete uptake and adds economic and logistical burdens. Screening coverage is also insufficient, with gaps between willingness and participation.
Understanding barriers to HPV vaccination and screening, and evaluating cost-effective strategies, is critical for informing policy and strengthening prevention. This dissertation investigates barriers and facilitators across the cervical cancer prevention continuum in China, aiming to expand access to effective measures. Specifically, it (1) assesses parental attitudes toward HPV vaccination, (2) evaluates the cost-effectiveness of a two-dose domestic bivalent HPV vaccine in the National Immunization Program (NIP), and (3) explores barriers and facilitators to cervical cancer screening among women of reproductive age.
Collectively, these studies provide epidemiologic, economic, and behavioral evidence to inform prevention strategies. Chapter 2 used a serial cross-sectional design in Shanghai (2019: n=1,037; 2024: n=1,450) to examine parental acceptance of HPV vaccination and associated factors. Acceptance declined for boys and younger children but increased for girls. Coverage rose from 6% to 30%, mainly among older adolescents and young adults, while uptake among girls aged 9–14 remained minimal. Parents of older children were nearly four times more likely to vaccinate than those of younger children.
Both HPV-specific and general vaccine hesitancy were linked to lower uptake, with HPV-specific hesitancy accounting for about 24% of non-vaccination, highlighting the need for targeted communication to dispel myths and emphasize prevention benefits. Chapter 3 evaluated the cost-effectiveness of introducing the two-dose domestic bivalent vaccine (Cecolin®) into the NIP for girls aged 9–14, using a static Markov model. For a simulated cohort of 100,000 girls, the status quo projected 231.7 cervical cancer cases and 137.7 deaths.
A two-dose program reduced this to 146.8 cases and 87.4 deaths, preventing 84.9 cases and 50.3 deaths at an incremental cost-effectiveness ratio (ICER) of $2,444 per quality-adjusted life year (QALY), well below China’s willingness-to-pay threshold. A one-dose schedule was less effective but even more cost-effective (ICER $570/QALY). Sensitivity analyses confirmed robustness and suggested potential cost savings with lower vaccine prices. Chapter 4 applied an explanatory sequential mixed-methods design, guided by the Health Belief Model, to examine cervical cancer screening among women aged 18–45 (survey: n=746; interviews: n=20).
Self-reported coverage was 67.3%, though qualitative interviews suggested inflation due to misunderstandings of what constitutes screening. Many described one-time, symptom-driven testing without routine follow-up. Factors associated with screening included marital status, older age, sexual activity, higher education, and prior HPV vaccination. Qualitative findings highlighted additional barriers such as misconceptions, financial constraints, procedural discomfort, and negative provider interactions. This dissertation demonstrates that expanding HPV vaccination and screening in China can reduce disease burden and improve equity.
Tailored, community-informed interventions are critical for increasing uptake. Cost-effectiveness analysis provides guidance for optimizing resources and ensuring sustainability. These findings carry direct policy implications for China and offer insights for other LMICs, contributing to global efforts to eliminate cervical cancer as a public health threat.
Open the resolved locator · 10.7302/28124
Metadata licence: OpenAlex metadata (CC0)